Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Proliferation”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Early research (Phase 1)Study completedNCT00652691
What this trial is testing

Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 48
Not applicableStudy completedNCT00357071
What this trial is testing

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

Who this might be right for
Eye Diseases
National Eye Institute (NEI) 219
Not applicableStudy completedNCT02167204
What this trial is testing

18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the BrainPrimary Brain NeoplasmRecurrent Brain Neoplasm
University of Washington 9
Large-scale testing (Phase 3)Study completedNCT00510692
What this trial is testing

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

Who this might be right for
Familial Adenomatous Polyposis ColiFAP
S.L.A. Pharma AG 58
Testing effectiveness (Phase 2)WithdrawnNCT00252811
What this trial is testing

ZD1839 Effects on Cell Proliferation in Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)WithdrawnNCT01610544
What this trial is testing

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Who this might be right for
Carcinoma, Non-Small-Cell LungThymus Neoplasms
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03262441
What this trial is testing

MMF for HIV Reservoir Reduction

Who this might be right for
Human Immunodeficiency Virus I Infection
Fred Hutchinson Cancer Center 5
Early research (Phase 1)WithdrawnNCT04594031
What this trial is testing

US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease

Who this might be right for
Sickle Cell DiseaseUmbilical Cord BloodHematopoietic Cell Proliferation
ExCellThera inc.
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Early research (Phase 1)Ended earlyNCT02936206
What this trial is testing

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Who this might be right for
Breast Cancer
Icahn School of Medicine at Mount Sinai 2
Not applicableStudy completedNCT00257907
What this trial is testing

Immune Response to Mycobacterium Tuberculosis Infection

Who this might be right for
Latent Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 157
Not applicableActive Not RecruitingNCT07176338
What this trial is testing

Role of Metformin in Posterior Capsule Opacification

Who this might be right for
CataractDiabetes Mellitus Type 2
Vienna Institute for Research in Ocular Surgery 40
Not applicableStudy completedNCT03107273
What this trial is testing

Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.

Who this might be right for
Hematopoietic Cell ProliferationMyelodysplastic Syndromes
Centre Hospitalier Universitaire, Amiens 35
Not applicableNot Yet RecruitingNCT05779124
What this trial is testing

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

Who this might be right for
Kidney TransplantationKidney Transplant Rejection
First Affiliated Hospital, Sun Yat-Sen University 176
Not applicableStudy completedNCT01403181
What this trial is testing

Effect of Boceprevir on HCV-specific T Cell Responses

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliero-Universitaria di Parma 30
Not applicableStudy completedNCT00972439
What this trial is testing

Oral Contraceptive (OC) Progestin Dose and Breast Proliferation

Who this might be right for
Oral Contraceptive
University of Southern California 33
Not applicableLooking for participantsNCT00902447
What this trial is testing

Human Blood Cell Disorders Tissue Bank

Who this might be right for
Human Blood Cell DisordersLymphoid, Myeloid and Erythroid Proliferative Disease
Northwell Health 10,000
Early research (Phase 1)Ended earlyNCT04596033
What this trial is testing

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more
Genocea Biosciences, Inc. 49
Not applicableStudy completedNCT05217147
What this trial is testing

An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma

Who this might be right for
Larynx CancerLarynx Carcinoma
Hacettepe University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191
What this trial is testing

Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Novartis Pharmaceuticals 568
Load More Results